The World Health Organization said on June 1 it has approved a Covid-19 vaccine made by drugmaker Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
The World Health Organization (WHO) approved for emergency use a Covid-19 vaccine from China’s state-owned drugmaker Sinopharm on May 7, bolstering Beijing’s push for a bigger role in inoculating the world.
The World Health Organization expects to release its assessments for emergency use listing of the two main Chinese vaccines for Covid-19 as well as the Moderna shot by the end of next week, WHO Assistant Director-General Mariangela Simao said on April 30.
Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm’s Covid-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on April 22.
Johnson & Johnson submitted data to the World Health Organization (WHO) for emergency use listing of the company’s Covid-19 vaccine, which would allow for wider access of the one-dose shot.
The World Health Organization listed AstraZeneca’s Covid-19 vaccine for emergency use, widening access in the developing world, while sources said the EU is in talks with Moderna on buying more vaccines.
The World Health Organization (WHO) on Feb. 15 listed AstraZeneca and Oxford University’s Covid-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.
